Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid Cancer.
Thyroid. 2021 Oct;31(10):1531-1541. doi: 10.1089/thy.2021.0091.
Thyroid. 2021.
PMID: 34405734